Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have lower amylin levels, which are not related to their body weight.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

People with chronic hives should be tested for thyroid autoimmunity to manage their condition better.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Not all hair loss patients need lab tests; patient history and physical exams are key to deciding who does.

The document explains how male reproductive hormones work and affect the body.

Platelet-rich plasma injections are a cheap and effective way to reduce hair loss and improve hair quality in people with mild to moderate androgenetic alopecia.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Women with telogen effluvium should be tested first for vitamin and mineral deficiencies.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.